What makes nasal delivery systems more challenging than solid dosage forms? How safe is nasal drug delivery? Are there such things as safe excipients? How does all this fit within the regulatory environment in Europe and the USA? How difficult is it to bring all these products to market?
This seminar seeks to explore these and other questions within the field of nasal drug delivery while reviewing interesting new data, innovative technologies and the very latest scientific developments. Leading authorities in nasal drug delivery will cover relevant aspects of nasal physiology, anatomy, absorption of a variety of drugs in various phases of drug development, and new drugs entering the market. In addition, nasal delivery to the sinuses will be discussed and the programme will include interesting case histories.
This seminar will offer an excellent networking opportunity to build business relationships and discuss all these issues with an unrivalled panel of experts in this field of drug delivery.
Those already involved in nasal drug delivery will benefit from updating their knowledge and sharing experiences with some of the leading practitioners in this field. If you are involved in nasal drug delivery or are just considering the potential, this seminar is an excellent route to understanding all aspects from the basic physiology through to launching a successful product.
1. Gain an update on the very latest scientific developments and technology advances in this field.
2. Hear from an unrivalled panel of expert speakers.
3. An excellent networking opportunity to build business relationships.
Nasal drugs to treat nasal disorders: a comprehensive review
Nasal drug delivery challenges
Nasal formulation of drugs
Developing next generation powder nasal delivery using POD technology
Rethinking nasal packaging environment
Key insights for a successful device development to achieve nasal bioequivalence requirements
The unique challenges of nasal drug delivery to treat chronic rhinosinusitis (CRS); considerations before and after sinus surgery
Review of day one
Dr Julie Suman and Dr René Bommer
Review of nasal drug delivery devices
Requirements concerning bioequivalence of nasal drug products from an authority’s point of view
Regulatory science associated with BE/TE for nasal products
US/FDA regulatory guidance on combination products
Qualification of new nasal drug delivery systems for existing drugs
Investigations regarding the developability of nasal metered dose inhalers
What are chemisimilars and what’s the problem?
Close of conference and refreshments
We do not currently have dates confirmed for this course; please contact us to be informed when it is scheduled; or to discuss running this course on an in-house basis for your staff.